AB661
☆    

India,
2025-04-02 13:39
(21 d 08:39 ago)

(edited on 2025-04-02 13:56)
Posting: # 24391
Views: 415
 

 Erythromycin Ethyl­succinate Tablet [Regulatives / Guidelines]

Post reply
Dear Team,

Query is with reference to Erythromycin Ethylsuccinate Tablet BE study Submission to US FDA

For Erythromycin Ethylsuccinate whether there are any literature evidences to provide that it is Highly variable drug.

Also, as per current OGD BE recommendation bioequivalence to be established based on Erythromycin Ethylsuccinate. But Erythromycin Ethylsuccinate is unstable in plasma and rapidly hydrolyzed to Erythromycin. Measuring analyte as erythromycin Ethylsuccinate will not give reliable result. Instead of Erythromycin Ethylsuccinate total Erythromycin to be measured. Can you please provide comments on this aspect?


With regards
AB661
 
dshah
★★  

India,
2025-04-10 07:19
(13 d 14:59 ago)

@ AB661
Posting: # 24397
Views: 213
 

 Erythromycin Ethyl­succinate Tablet

Post reply
Hello AB661

❝ For Erythromycin Ethylsuccinate whether there are any literature evidences to provide that it is Highly variable drug.

You need to check with data

❝ Also, as per current OGD BE recommendation bioequivalence to be established based on Erythromycin Ethylsuccinate. But Erythromycin Ethylsuccinate is unstable in plasma and rapidly hydrolyzed to Erythromycin. Measuring analyte as erythromycin Ethylsuccinate will not give reliable result. Instead of Erythromycin Ethylsuccinate total Erythromycin to be measured. Can you please provide comments on this aspect?

There are methods available and so develop accordingly. As the AE with ethylsuccinate are less, it also makes sense to analyze them. PSG recommends BE based on parent salt form, and free base as supportive evidence.

Divyen
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
21 visitors (0 registered, 21 guests [including 0 identified bots]).
Forum time: 22:19 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5